Hormone therapy during perimenopause may slow down aging in menopausal women without increasing mortality risks, according to a recent study published in JAMA Network Open. The study found that women who received hormone therapy exhibited fewer indications of aging compared to those who did not. This effect was most significant in women of lower socioeconomic status, leveling out their mortality risk with women in higher-income categories. The study analyzed data from 117,763 postmenopausal women in the UK Biobank, revealing that starting hormone therapy at age 48.4 years for four to eight years had the strongest anti-aging effect.
Perimenopause, the period directly preceding menopause, is the time during which hormone therapy is most likely to be beneficial. This phase is characterized by irregular periods and fluctuating estrogen production, leading to symptoms such as hot flashes and vaginal dryness. Hormone therapy can help ease this transition into menopause, according to G. Thomas Ruiz, MD, an OB/GYN at MemorialCare Orange Coast Medical Center. Women in their early 40s or younger may also benefit from hormone therapy if they experience premature menopause or undergo certain procedures.
The study also highlighted the association between hormone therapy and decreased aging discrepancy among women with disadvantaged socioeconomic status. Hormone therapy may help offset the mortality risks associated with aging in this population. However, caution should be exercised in interpreting causation, as individuals with higher socioeconomic status may not experience the same benefits from hormone therapy. It is important to consider individual health needs and risks when deciding on hormone therapy during perimenopause.
Postmenopausal hormone therapy, known as hormone replacement therapy, has been a topic of controversy for many years. Early studies like the Women’s Health Initiative suggested increased risks of dementia and stroke with hormone therapy use in postmenopausal women. However, recent research indicates that timing plays a crucial role in the benefits and risks of hormone therapy. Hormone therapy during perimenopause may be helpful for slowing down aging and maintaining overall health, particularly for women with lower socioeconomic status.
Maintaining bone health is crucial for menopausal women, as estrogen plays a significant role in calcium absorption and bone strength. Hormone replacement therapy may help support bone health by ensuring a steady rate of calcium entering the bones. Additionally, estrogen receptors in the skin and vaginal mucosa contribute to maintaining a youthful appearance and normal tissue thickness. It is important for women considering hormone therapy to undergo lipid testing for heart health and mammograms for breast cancer monitoring.
Experts recommend incorporating physical activity into daily routines as a safer alternative to medication for promoting bone, heart, and cognitive health. While hormone therapy may offer benefits for menopausal women, it is essential to carefully consider individual health factors and risks before starting treatment. The timing of hormone therapy, particularly during perimenopause, may offer the most significant benefits in slowing down aging and maintaining overall well-being.
